Avitas Wealth Management LLC Biogen Inc. Transaction History

Avitas Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 18, 2019	SELL	$217.44 - $243.88 $1.77 Million - $1.98 Million	-8,133 Closed	0 $0
Q2 2019 Jul 23, 2019	SELL	$219.29 - $241.72 $413,361 - $455,642	-1,885 Reduced 18.82%	8,133 $1.9 Million
Q1 2019 May 01, 2019	BUY	$216.71 - $338.96 $5,201 - $8,135	24 Added 0.24%	10,018 $2.37 Million
Q4 2018 Feb 08, 2019	SELL	$278.5 - $352.75 $23,394 - $29,631	-84 Reduced 0.83%	9,994 $3.01 Million
Q3 2018 Dec 19, 2018	SELL	$293.51 - $383.83 $3,815 - $4,989	-13 Reduced 0.13%	10,078 $3.56 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $61,637 - $80,604	210 Added 2.13%	10,091 $3.57 Million
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $2.54 Million - $3.03 Million	9,881 New	9,881 $2.87 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Avitas Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Avitas Wealth Management LLC with notifications on news.